Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MICB is a stress-induced ligand structurally related to MHC class I molecules. It binds to the activating receptor NKG2D on NK cells and some T cells, triggering immune responses against cells experiencing stress, such as those infected with viruses or undergoing transformation.
NKG2D receptor activation leading to NK cell-mediated cytotoxicity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Major Histocompatibility Complex Class I-Related Protein B (MICB).